PAPER
Photoswitchable Macrocycles
3355
[2,3-(10-Methyl-9-phenylacridinium)]-(1¢,2¢-phenyl)-24-crown-
8 Chloride (18)
HRMS-ESI: m/z [M + H]+ calcd for C40H50NO9: 688.3480; found:
688.3478.
Prepared from 10 following the procedure described for 16 above.
HRMS-ESI: m/z [M + H + Na]2+ calcd for C40H50NNaO9: 355.6686;
Yield: 0.25 g (54%); Rf = 0.2 [MeOH–H2O–aq NH4Cl (7 M),
found: 355.6684.
20:6:0.1]; mp 70–72 °C.
UV/Vis (n-propanol): lmax (e) = 278 nm (29000).
1H NMR (CDCl3): d = 3.75 (m, 8 H, H-25,26,27,28), 3.82 (m, 8 H,
H-21,23,29,30), 3.88 (m, 2 H, H-24), 3.98 (m, 4 H, H-31,32), 4.92
(m, 2 H, H-22), 5.02 (br s, 3 H, NCH3), 6.66 (m, 4 H, H-
35,36,37,38), 6.69 (s, 1 H, H-1), 7.21 (m, 2 H, H-16,20), 7.59 (m,
4 H, H-7,17,18,19), 7.68 (d, J = 8.3 Hz, 1 H, H-8), 8.18 (m, 1 H, H-
6), 8.23 (s, 1 H, H-4), 8.57 (d, J = 9.0 Hz, 1 H, H-5).
13C NMR (CDCl3): d = 40.3 (CH3, NCH3), 68.9, 69.0, 69.1, 69.2,
69.5, 69.8, 69.9, 71.0, 71.1, 71.3, 71.5, 72.0 (C-
21,22,23,24,25,26,27,28,29,30,31,32), 99.5 (C-1), 105.7 (C-4),
113.6 (C-36,37), 118.2 (C-5), 121.2 (C-35,38), 122.8 (C-13), 124.5
(C-14), 126.7 (C-6), 129.1 (C-8,16,17,19,20), 130.2 (C-18), 135.8
(C-7), 139.1 (C-12), 141.5 (C-11), 148.6 (C-2), 150.1 (C-3), 154.8
(C-33,34), 160.7 (C-15).
2,3-(10-Methyl-9-phenylacridinium)crown-4 Chloride (20)
Obtained according to the general procedure used for the synthesis
of compound 12 and isolated as the chloride.
Yield: 0.22 g (46%); mp 43–45 °C.
1H NMR (CD3CN): d = 3.65 (m, 6 H, H-22,23,24), 3.94 (t, J = 4.1
Hz, 2 H, H-25), 4.15 (t, J = 4.6 Hz, 4 H, H-21), 4.63 (t, J = 4.5 Hz,
2 H, H-26), 4.71 (s, 3 H, NCH3), 7.27 (s, 1 H, H-1), 7.48 (m, 2 H,
H-16,20), 7.72 (m, 4 H, H-7,17,18,19), 7.79 (s, 1 H, H-4), 7.86 (dd,
J = 8.7, 1.5 Hz, 1 H, H-8), 8.22 (dt, J = 9.0, 1.5 Hz, 1 H, H-6), 8.50
(d, J = 9.4 Hz, 1 H, H-5).
13C NMR (CD3CN): d = 40.4 (NCH3), 69.7 (C-25), 70.5 (C-22),
71.9 (C-23,24), 73.9 (C-26), 75.8 (C-21), 102.4 (C-4), 116.7 (C-1),
119.5 (C-5), 124.8 (C-13), 126.5 (C-14), 128.5 (C-7), 130.9 (C-
17,18,19), 131.0 (C-8), 131.2 (C-16,20), 135.2 (C-12), 137.7 (C-6),
141.6 (C-11), 153.4 (C-2), 158.6 (C-3), 164.4 (C-15).
Anal. Calcd for C38H42NO8Cl: C, 67.50; H, 6.26; N, 2.07; Cl, 5.24.
Found: C, 67.64; H, 6.51; N, 2.21; Cl, 5.30.
HRMS-ESI: m/z [M – Cl]+ calcd for C38H42NO8: 640.2910; found:
640.2916.
Anal. Calcd for C26H26ClNO4: C, 69.10; H, 5.80; N, 3.10. Found: C,
68.83; H, 5.53; N, 2.99.
UV/Vis (n-propanol): lmax (e) = 277 (44000), 397 nm (8500).
HRMS-ESI: m/z [M – Cl]+ calcd for C26H26NO4: 416.1856; found:
416.1861.
[2,7-(10-Methyl-9-phenyl-9-methoxyacridane)]-(1¢,2¢-phenyl)-
29-crown-8 (17)
Obtained according to the general procedure, using toluene instead
of CHCl3.
2,7-Bis{2-[2-(2-hydroxyethoxy)ethoxy]ethoxy}-10-methyl-9-
phenylacridinium Chloride (21)
Mp 68–73 °C.
Compound 1 (1.9 g, 7.15 mmol) dissolved in anhydrous THF (120
mL) was added to a boiling solution of the Grignard-compound pre-
pared from bromobenzene (2.23 g, 14.3 mmol) and Mg (0.38 g) in
THF (30 mL). The reaction mixture was heated under reflux for 24
h then filtered and the filtrate was evaporated. The remaining resi-
due was purified by column chromatography [MeOH–H2O–aq
NH4Cl (7 M), 12:3:0.1] and the yellow fractions containing the
product were combined and evaporated. The remaining solid was
dissolved in MeCN, filtered and the solvent was removed in vacuo
to give 2,7-dimethoxy-10-methyl-9-phenylacridinium chloride.
1H NMR (CDCl3): d = 3.05 (s, 3 H, OCH3), 3.36 (s, 3 H, NCH3),
3.65 (m, 8 H, H-23,23¢,24,24¢), 3.68 (m, 4 H, H-25,25¢), 3.76 (t,
J = 6.0 Hz, 4 H, H-22,22¢), 4.10 (m, 8 H, H-21,21¢,26,26¢), 6.87 (s,
6 H, H-4,5,3¢,4¢,5¢,6¢), 7.02 (d, J = 1.5 Hz, 2 H, H-3,6), 7.10 (d,
J = 7.1 Hz, 1 H, H-18), 7.23 (t, J = 7.5 Hz, 2 H, H-17,19), 7.25 (s,
2 H, H-1,8), 7.31 (d, J = 7.5 Hz, 2 H).
13C NMR (CDCl3): d = 33.4 (CH3, NCH3), 51.3 (CH3, OCH3), 68.1,
68.9, 69.5, 69.7, 70.7 (CH2), 100.8 (Cq), 112.9 (CH), 114.3 (CH),
115.8 (CH), 116.9 (CH), 121.3 (Cq), 124.6 (CH), 126.0 (CH), 126.4
(CH), 127.8 (CH), 135.1 (Cq), 136.1 (Cq), 148.8 (Cq), 152.0 (Cq).
Yield: 1.4 g (55%); yellow solid; mp 182–185 °C.
1H NMR (CD3OD): d = 4.00 (s, 6 H, OCH3), 5.15 (s, 3 H, NCH3),
7.29 (d, J = 3.0 Hz, 2 H), 7.79 (m, 2 H), 8.03 (m, 3 H), 8.20 (dd,
J = 3.0, 9.8 Hz, 2 H), 8.88 (d, J = 9.8 Hz, 2 H).
Anal. Calcd for C40H49NO9: C, 69.85; H, 7.18; N, 2.04. Found: C,
69.55; H, 7.21; N, 2.37.
[2,3-(10-Methyl-9-phenyl-9-methoxyacridane)]-(1¢,2¢-phenyl)-
13C NMR (CDCl3): d = 38.8 (NCH3), 55.9 (OCH3), 105.3 (CH),
119.9 (CH), 127.8 (Cq), 129.5 (CH), 129.9 (CH), 130.6 (CH), 130.8
(CH), 134.0 (Cq), 136.7 (Cq), 129.0 (Cq), 157.6 (Cq).
24-crown-8 (19)
Obtained according to the general procedure using toluene instead
of CHCl3.
Anal. Calcd for C22H20ClNO2: C, 72.16; H, 5.46; N, 3.82. Found: C,
71.95; H, 5.87; N, 3.94.
Mp 47–50 °C.
1H NMR (CDCl3): d = 2.90 (s, 3 H, OCH3), 3.45 (s, 3 H, NCH3),
3.67 (s, 8 H, H-25,26,27,28), 3.81 (m, 2 H, H-24), 3.75 (m, 6 H, H-
23,29,30), 4.04 (m, 6 H, H-21,31,32), 4.18 (m, 2 H, H-22), 6.66 (s,
1 H, H-4), 6.74 (s, 1 H, H-1), 6.84 (s, 6 H, H-5,7,35,36,37,38), 7.08
(t, J = 7.2 Hz, 2 H, H-17,19), 7.23 (m, 5 H, H-6,8,16,18,20).
13C NMR (CDCl3): d = 33.7 (CH3, NCH3), 56.1 (CH3, OCH3), 68.8,
69.7, 69.9, 70.7, 70.8, 71.3 (C-21,22,23,24,25,26,27,28,29,30,
31,32), 97.2 (C-9), 112.1 (C-4), 114.9 (C-36,37), 115.5 (C-8), 119.9
(C-5), 121.4 (C-7), 121.6 (C-35,38), 124.0 (C-13), 125.8 (C-14),
126.1 (C-18), 126.6 (C-16,20), 127.6 (C-17,19), 128.2 (C-6), 134.9
(C-11), 140.8 (C-12), 142.4 (C-2), 143.1 (C-15), 145.4 (C-3), 150.7
(C-33,34).
HRMS-ESI: m/z [M – Cl]+ calcd for C22H20NO2: 330.1489; found:
330.1492.
2,7-Dimethoxy-10-methyl-9-phenylacridinium chloride (1 g, 3.0
mmol), dissolved in aq HBr (47%, 20 mL), was heated under reflux
for 2 h. The solvent was removed in vacuo and the crude product
was recrystallized from MeOH to give 2,7-dihydroxy-10-methyl-9-
phenylacridinium bromide.
Yield: 1.06 g (92%); yellow-orange solid; mp 210–214 °C.
1H NMR (CD3OD): d = 4.87 (s, 3 H, NCH3), 7.06 (d, J = 2.6 Hz,
2 H), 7.50 (m, 2 H), 7.73 (m, 3 H), 7.88 (dd, J = 2.6, 9.8 Hz, 2 H),
8.60 (d, J = 9.8 Hz, 2 H).
13C NMR (CD3OD): d = 38.1 (NCH3), 107.6 (CH), 120.1 (CH),
128.4 (Cq), 129.0 (CH), 129.9 (CH), 129.0 (CH), 129.5 (CH), 129.6
(CH), 130.6 (CH), 134.7 (Cq), 135.9 (Cq), 153.9 (Cq), 156.6 (Cq).
Anal. Calcd for C40H49NO9: C, 69.85; H, 7.18; N, 2.04. Found: C,
69.90 H, 6.83; N, 2.09.
Synthesis 2007, No. 21, 3345–3356 © Thieme Stuttgart · New York